Literature DB >> 12495673

Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa.

Charlotta Sundin1, Matthew C Wolfgang, Stephen Lory, Ake Forsberg, Elisabet Frithz-Lindsten.   

Abstract

The type III secretion system (TTSS) of the opportunistic pathogen Pseudomonas aeruginosa enables the bacterium to deliver exoenzymes directly into the eukaryotic cell. In this study we have investigated the role of key factors involved in this process. We could demonstrate that the translocators PopB, PopD and PcrV are absolutely required for delivery of Exoenzyme S into host cells. By analyzing different Tfp (type IV pili) mutants we could establish a correlation between the frequency of bacteria binding to the host cell and the levels of translocated ExoS, thereby verifying that the process is contact dependent. However, there was no absolute requirement for the Tfp per se, since the pilus could be substituted with a different type of adhesin, the non-fimbrial adhesin pH6 antigen of Yersinia pestis. Taken together, our results demonstrate that binding to establish close contact between the type III secretion organelle and the host cell is essential for translocation, while the additional activities of Tfp are not essential for the delivery of TTSS proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12495673     DOI: 10.1006/mpat.2002.0534

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  43 in total

1.  The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains.

Authors:  Jan Olsson; Petra J Edqvist; Jeanette E Bröms; Ake Forsberg; Hans Wolf-Watz; Matthew S Francis
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 2.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Infection of human mucosal tissue by Pseudomonas aeruginosa requires sequential and mutually dependent virulence factors and a novel pilus-associated adhesin.

Authors:  Ryan W Heiniger; Hanne C Winther-Larsen; Raymond J Pickles; Michael Koomey; Matthew C Wolfgang
Journal:  Cell Microbiol       Date:  2010-03-12       Impact factor: 3.715

4.  ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Isabelle Vallet-Gely; Simon L Dove; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

5.  Regulatory role of PopN and its interacting partners in type III secretion of Pseudomonas aeruginosa.

Authors:  Hongjing Yang; Zhiying Shan; Jaewha Kim; Weihui Wu; Wei Lian; Lin Zeng; Laijun Xing; Shouguang Jin
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

6.  ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa.

Authors:  Michelle Cisz; Pei-Chung Lee; Arne Rietsch
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

7.  Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide.

Authors:  Luyan Ma; Haiping Lu; April Sprinkle; Matthew R Parsek; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2007-07-13       Impact factor: 3.490

8.  Characterization of molten globule PopB in absence and presence of its chaperone PcrH.

Authors:  Supratim Dey; Abhishek Basu; Saumen Datta
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

9.  Genetic and functional analyses of PptA, a phospho-form transferase targeting type IV pili in Neisseria gonorrhoeae.

Authors:  Cecilia L Naessan; Wolfgang Egge-Jacobsen; Ryan W Heiniger; Matthew C Wolfgang; Finn Erik Aas; Asmund Røhr; Hanne C Winther-Larsen; Michael Koomey
Journal:  J Bacteriol       Date:  2007-10-19       Impact factor: 3.490

10.  Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Matthew C Wolfgang; John J Mekalanos
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.